Pia Renaudin is SciBase’s new CEO, effective October 1st, 2023.  

Pia Renaudin is SciBase’s new Chief Executive Officer (CEO), effective October 1st, 2023.  

 SciBase's products include Nevisense and Nevisense Go and address melanoma detection, non-melanoma skin cancer detection and skin barrier assessment.

Ms. Renaudin has spent more than 20 years in companies such as Senzime AB, Gilead Sciences, Stryker, and AstraZeneca. She joins SciBase from Senzime AB, a Swedish MedTech Company where was CEO from 2019 to 2023. 

"I am thrilled to be joining SciBase at this transformative stage, following the positive reimbursement news,” says Ms. Renaudin.” I am looking forward to lead and expand SciBase to become a successful commercial entity for the benefit of patients and all other stakeholders in my new role as CEO. I am convinced we have a very exciting future with great growth potential ahead of us".

Simon Grant resigned from his position as CEO for personal reasons and will remain with the Company until the end of October to fully support the transition.